{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T15:39:47Z","timestamp":1740152387663,"version":"3.37.3"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"TUTCM Graduate Research Innovation Project","award":["YJSKC-20232007"],"award-info":[{"award-number":["YJSKC-20232007"]}]},{"DOI":"10.13039\/100014717","name":"National Outstanding Youth Science Fund Project of National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82405123"],"award-info":[{"award-number":["82405123"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BioData Mining"],"DOI":"10.1186\/s13040-024-00405-w","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T08:11:16Z","timestamp":1731053476000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigating potential drug targets for IgA nephropathy and membranous nephropathy through multi-queue plasma protein analysis: a Mendelian randomization study based on SMR and co-localization analysis"],"prefix":"10.1186","volume":"17","author":[{"given":"Xinyi","family":"Xu","sequence":"first","affiliation":[]},{"given":"Changhong","family":"Miao","sequence":"additional","affiliation":[]},{"given":"Shirui","family":"Yang","sequence":"additional","affiliation":[]},{"given":"Lu","family":"Xiao","sequence":"additional","affiliation":[]},{"given":"Ying","family":"Gao","sequence":"additional","affiliation":[]},{"given":"Fangying","family":"Wu","sequence":"additional","affiliation":[]},{"given":"Jianbo","family":"Xu","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,11,8]]},"reference":[{"issue":"2","key":"405_CR1","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1093\/ndt\/gfq665","volume":"26","author":"A McGrogan","year":"2011","unstructured":"McGrogan A, Franssen CF, de Vries CS. The incidence of primary glomerulonephritis worldwide: a systematic review of the literature. Nephrol Dial Transpl. 2011;26(2):414\u201330. https:\/\/doi.org\/10.1093\/ndt\/gfq665.","journal-title":"Nephrol Dial Transpl"},{"issue":"Suppl 2","key":"405_CR2","doi-asserted-by":"publisher","first-page":"i1","DOI":"10.1093\/ckj\/sfad199","volume":"16","author":"M Lee","year":"2023","unstructured":"Lee M, Suzuki H, Nihei Y, Matsuzaki K, Suzuki Y. Ethnicity and IgA nephropathy: worldwide differences in epidemiology, timing of diagnosis, clinical manifestations, management and prognosis. Clin Kidney J. 2023;16(Suppl 2):i1\u20138. https:\/\/doi.org\/10.1093\/ckj\/sfad199.","journal-title":"Clin Kidney J"},{"issue":"1","key":"405_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000484717","volume":"4","author":"JH Hou","year":"2018","unstructured":"Hou JH, Zhu HX, Zhou ML, Le WB, Zeng CH, Liang SS, et al. Changes in the spectrum of kidney diseases: an analysis of 40,759 biopsy-proven cases from 2003 to 2014 in China. Kidney Dis (Basel). 2018;4(1):10\u20139. https:\/\/doi.org\/10.1159\/000484717.","journal-title":"Kidney Dis (Basel)"},{"issue":"4","key":"405_CR4","doi-asserted-by":"publisher","first-page":"677","DOI":"10.2215\/CJN.07420716","volume":"12","author":"JC Rodrigues","year":"2017","unstructured":"Rodrigues JC, Haas M, Reich HN. IgA nephropathy. Clin J Am Soc Nephrol. 2017;12(4):677\u201386. https:\/\/doi.org\/10.2215\/CJN.07420716.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"405_CR5","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1093\/ckj\/sfaa029","volume":"14","author":"T Robert","year":"2021","unstructured":"Robert T, Jantzen R, Cambier A, Jamme M, Couchoud C, Brunet P, et al. Spatiotemporal trends and prognosis of end-stage renal disease patients with biopsy-proven immunoglobulin a nephropathy in France from 2010 to 2014. Clin Kidney J. 2021;14(3):898\u2013908. https:\/\/doi.org\/10.1093\/ckj\/sfaa029.","journal-title":"Clin Kidney J"},{"issue":"1","key":"405_CR6","doi-asserted-by":"publisher","first-page":"2195012","DOI":"10.1080\/0886022X.2023.2195012","volume":"45","author":"ZY Tian","year":"2023","unstructured":"Tian ZY, Li Z, Chu L, Liu Y, He JR, Xin Y, et al. Iron metabolism and chronic inflammation in IgA nephropathy. Ren Fail. 2023;45(1):2195012. https:\/\/doi.org\/10.1080\/0886022X.2023.2195012.","journal-title":"Ren Fail"},{"issue":"5","key":"405_CR7","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/ki.2013.210","volume":"84","author":"SJ Barbour","year":"2013","unstructured":"Barbour SJ, Cattran DC, Kim SJ, Levin A, Wald R, Hladunewich MA, et al. Individuals of pacific Asian origin with IgA nephropathy have an increased risk of progression to end-stage renal disease. Kidney Int. 2013;84(5):1017\u201324. https:\/\/doi.org\/10.1038\/ki.2013.210.","journal-title":"Kidney Int"},{"issue":"9","key":"405_CR8","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1111\/nep.13592","volume":"24","author":"SC Yeo","year":"2019","unstructured":"Yeo SC, Goh SM, Barratt J. Is immunoglobulin a nephropathy different in different ethnic populations? Nephrol (Carlton). 2019;24(9):885\u201395. https:\/\/doi.org\/10.1111\/nep.13592.","journal-title":"Nephrol (Carlton)"},{"issue":"1","key":"405_CR9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41572-023-00476-9","volume":"9","author":"E Stamellou","year":"2023","unstructured":"Stamellou E, Seikrit C, Tang S, Boor P, Tesa\u0159 V, Floege J, et al. IgA nephropathy. Nat Rev Dis Primers. 2023;9(1):67. https:\/\/doi.org\/10.1038\/s41572-023-00476-9.","journal-title":"Nat Rev Dis Primers"},{"issue":"Suppl 1","key":"405_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1159\/000481635","volume":"47","author":"AS Bomback","year":"2018","unstructured":"Bomback AS, Fervenza FC. Membranous nephropathy: approaches to treatment. Am J Nephrol. 2018;47(Suppl 1):30\u201342. https:\/\/doi.org\/10.1159\/000481635.","journal-title":"Am J Nephrol"},{"issue":"5","key":"405_CR11","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1093\/nar\/gky092","volume":"46","author":"UniProt CT","year":"2018","unstructured":"UniProt CT. UniProt: the universal protein knowledgebase. Nucleic Acids Res. 2018;46(5):2699. https:\/\/doi.org\/10.1093\/nar\/gky092.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"405_CR12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13326-016-0102-0","volume":"7","author":"P Mutowo","year":"2016","unstructured":"Mutowo P, Bento AP, Dedman N, Gaulton A, Hersey A, Lomax J, et al. A drug target slim: using gene ontology and gene ontology annotations to navigate protein-ligand target space in ChEMBL. J Biomed Semant. 2016;7(1):59. https:\/\/doi.org\/10.1186\/s13326-016-0102-0.","journal-title":"J Biomed Semant"},{"issue":"2","key":"405_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/d41573-019-00014-x","volume":"18","author":"A Mullard","year":"2019","unstructured":"Mullard A. 2018 FDA drug approvals. Nat Rev Drug Discov. 2019;18(2):85\u20139. https:\/\/doi.org\/10.1038\/d41573-019-00014-x.","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"405_CR14","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/ng.3314","volume":"47","author":"MR Nelson","year":"2015","unstructured":"Nelson MR, Tipney H, Painter JL, Shen J, Nicoletti P, Shen Y, et al. The support of human genetic evidence for approved drug indications. Nat Genet. 2015;47(8):856\u201360. https:\/\/doi.org\/10.1038\/ng.3314.","journal-title":"Nat Genet"},{"issue":"10","key":"405_CR15","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/s41576-021-00387-z","volume":"22","author":"WR Reay","year":"2021","unstructured":"Reay WR, Cairns MJ. Advancing the use of genome-wide association studies for drug repurposing. Nat Rev Genet. 2021;22(10):658\u201371. https:\/\/doi.org\/10.1038\/s41576-021-00387-z.","journal-title":"Nat Rev Genet"},{"issue":"16","key":"405_CR16","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1161\/CIRCULATIONAHA.121.056663","volume":"145","author":"A Henry","year":"2022","unstructured":"Henry A, Gordillo-Mara\u00f1\u00f3n M, Finan C, Schmidt AF, Ferreira JP, Karra R, et al. Therapeutic targets for heart failure identified using proteomics and mendelian randomization. Circulation. 2022;145(16):1205\u201317. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.056663.","journal-title":"Circulation"},{"issue":"10","key":"405_CR17","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1161\/CIRCULATIONAHA.119.040180","volume":"140","author":"M Chong","year":"2019","unstructured":"Chong M, Sjaarda J, Pigeyre M, Mohammadi-Shemirani P, Lali R, Shoamanesh A, et al. Novel drug targets for ischemic stroke identified through mendelian randomization analysis of the blood proteome. Circulation. 2019;140(10):819\u201330. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.040180.","journal-title":"Circulation"},{"issue":"16","key":"405_CR18","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","volume":"326","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova VW, Richmond RC, Woolf B, Yarmolinsky J, Davies NM, Swanson SA, et al. Strengthening the reporting of Observational studies in Epidemiology using mendelian randomization: the STROBE-MR Statement. JAMA. 2021;326(16):1614\u201321. https:\/\/doi.org\/10.1001\/jama.2021.18236.","journal-title":"JAMA"},{"issue":"10","key":"405_CR19","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/s41588-020-0682-6","volume":"52","author":"J Zheng","year":"2020","unstructured":"Zheng J, Haberland V, Baird D, Walker V, Haycock PC, Hurle MR, et al. Phenome-wide mendelian randomization mapping the influence of the plasma proteome on complex diseases. Nat Genet. 2020;52(10):1122\u201331. https:\/\/doi.org\/10.1038\/s41588-020-0682-6.","journal-title":"Nat Genet"},{"key":"405_CR20","doi-asserted-by":"publisher","first-page":"14357","DOI":"10.1038\/ncomms14357","volume":"8","author":"K Suhre","year":"2017","unstructured":"Suhre K, Arnold M, Bhagwat AM, Cotton RJ, Engelke R, Raffler J, et al. Connecting genetic risk to disease end points through the human blood plasma proteome. Nat Commun. 2017;8:14357. https:\/\/doi.org\/10.1038\/ncomms14357.","journal-title":"Nat Commun"},{"issue":"7708","key":"405_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41586-018-0175-2","volume":"558","author":"BB Sun","year":"2018","unstructured":"Sun BB, Maranville JC, Peters JE, Stacey D, Staley JR, Blackshaw J, et al. Genomic atlas of the human plasma proteome. Nature. 2018;558(7708):73\u20139. https:\/\/doi.org\/10.1038\/s41586-018-0175-2.","journal-title":"Nature"},{"issue":"1","key":"405_CR22","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.1038\/s41467-018-05512-x","volume":"9","author":"C Yao","year":"2018","unstructured":"Yao C, Chen G, Song C, Keefe J, Mendelson M, Huan T, et al. Genome-wide mapping of plasma protein QTLs identifies putatively causal genes and pathways for cardiovascular disease. Nat Commun. 2018;9(1):3268. https:\/\/doi.org\/10.1038\/s41467-018-05512-x.","journal-title":"Nat Commun"},{"issue":"6404","key":"405_CR23","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1126\/science.aaq1327","volume":"361","author":"V Emilsson","year":"2018","unstructured":"Emilsson V, Ilkov M, Lamb JR, Finkel N, Gudmundsson EF, Pitts R, et al. Co-regulatory networks of human serum proteins link genetics to disease. Science. 2018;361(6404):769\u201373. https:\/\/doi.org\/10.1126\/science.aaq1327.","journal-title":"Science"},{"issue":"4","key":"405_CR24","doi-asserted-by":"publisher","first-page":"e1006706","DOI":"10.1371\/journal.pgen.1006706","volume":"13","author":"L Folkersen","year":"2017","unstructured":"Folkersen L, Fauman E, Sabater-Lleal M, Strawbridge RJ, Fr\u00e5nberg M, Sennblad B, et al. Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease. Plos Genet. 2017;13(4):e1006706. https:\/\/doi.org\/10.1371\/journal.pgen.1006706.","journal-title":"Plos Genet"},{"issue":"8","key":"405_CR25","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1093\/brain\/awad070","volume":"146","author":"J Lin","year":"2023","unstructured":"Lin J, Zhou J, Xu Y. Potential drug targets for multiple sclerosis identified through mendelian randomization analysis. Brain. 2023;146(8):3364\u201372. https:\/\/doi.org\/10.1093\/brain\/awad070.","journal-title":"Brain"},{"issue":"12","key":"405_CR26","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","volume":"53","author":"E Ferkingstad","year":"2021","unstructured":"Ferkingstad E, Sulem P, Atlason BA, Sveinbjornsson G, Magnusson MI, Styrmisdottir EL, et al. Large-scale integration of the plasma proteome with genetics and disease. Nat Genet. 2021;53(12):1712\u201321. https:\/\/doi.org\/10.1038\/s41588-021-00978-w.","journal-title":"Nat Genet"},{"issue":"9","key":"405_CR27","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","volume":"53","author":"U V\u00f5sa","year":"2021","unstructured":"V\u00f5sa U, Claringbould A, Westra HJ, Bonder MJ, Deelen P, Zeng B, et al. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat Genet. 2021;53(9):1300\u201310. https:\/\/doi.org\/10.1038\/s41588-021-00913-z.","journal-title":"Nat Genet"},{"issue":"1","key":"405_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/gepi.22506","volume":"47","author":"A Gkatzionis","year":"2023","unstructured":"Gkatzionis A, Burgess S, Newcombe PJ. Statistical methods for cis-mendelian randomization with two-sample summary-level data. Genet Epidemiol. 2023;47(1):3\u201325. https:\/\/doi.org\/10.1002\/gepi.22506.","journal-title":"Genet Epidemiol"},{"issue":"1","key":"405_CR29","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1186\/s12967-023-04368-0","volume":"21","author":"M Jiang","year":"2023","unstructured":"Jiang M, Yan W, Zhang Y, Lu Z, Lu T, Zhang D, et al. Phosphodiesterase and psychiatric disorders: a two-sample mendelian randomization study. J Transl Med. 2023;21(1):560. https:\/\/doi.org\/10.1186\/s12967-023-04368-0.","journal-title":"J Transl Med"},{"issue":"11","key":"405_CR30","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1038\/s41588-018-0248-z","volume":"50","author":"O Canela-Xandri","year":"2018","unstructured":"Canela-Xandri O. An atlas of genetic associations in UK Biobank. Nat Genet. 2018;50(11):1593\u20139. https:\/\/doi.org\/10.1038\/s41588-018-0248-z.","journal-title":"Nat Genet"},{"key":"405_CR31","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000000922","author":"X Zou","year":"2023","unstructured":"Zou X, Wang L, Wang S, Zhang Y, Ma J, Chen L, et al. Promising therapeutic targets for ischemic stroke identified from plasma and cerebrospinal fluid proteomes: a multicenter mendelian randomization study. Int J Surg. 2023. https:\/\/doi.org\/10.1097\/JS9.0000000000000922.","journal-title":"Int J Surg"},{"doi-asserted-by":"publisher","unstructured":"Huang W, Xiao J, Ji J, Chen L. Association of lipid-lowering drugs with COVID-19 outcomes from a mendelian randomization study. Elife. 2021;10. https:\/\/doi.org\/10.7554\/eLife.73873.","key":"405_CR32","DOI":"10.7554\/eLife.73873"},{"issue":"3","key":"405_CR33","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.ekir.2022.12.011","volume":"8","author":"JE Rojas-Rivera","year":"2023","unstructured":"Rojas-Rivera JE, Ortiz A, Fervenza FC. Novel treatments paradigms: Membranous Nephropathy. Kidney Int Rep. 2023;8(3):419\u201331. https:\/\/doi.org\/10.1016\/j.ekir.2022.12.011.","journal-title":"Kidney Int Rep"},{"issue":"5","key":"405_CR34","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00281-021-00888-3","volume":"43","author":"J Floege","year":"2021","unstructured":"Floege J, Rauen T, Tang S. Current treatment of IgA nephropathy. Semin Immunopathol. 2021;43(5):717\u201328. https:\/\/doi.org\/10.1007\/s00281-021-00888-3.","journal-title":"Semin Immunopathol"},{"issue":"4","key":"405_CR35","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.drudis.2019.01.010","volume":"24","author":"RH Griesenauer","year":"2019","unstructured":"Griesenauer RH, Schillebeeckx C, Kinch MS. Assessing the public landscape of clinical-stage pharmaceuticals through freely available online databases. Drug Discov Today. 2019;24(4):1010\u20136. https:\/\/doi.org\/10.1016\/j.drudis.2019.01.010.","journal-title":"Drug Discov Today"},{"issue":"8","key":"405_CR36","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1093\/ndt\/gfu020","volume":"29","author":"T Kawamura","year":"2014","unstructured":"Kawamura T, Yoshimura M, Miyazaki Y, Okamoto H, Kimura K, Hirano K, et al. A multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy in patients with immunoglobulin A nephropathy. Nephrol Dial Transpl. 2014;29(8):1546\u201353. https:\/\/doi.org\/10.1093\/ndt\/gfu020.","journal-title":"Nephrol Dial Transpl"},{"issue":"4S","key":"405_CR37","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","volume":"100","author":"KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases","year":"2021","unstructured":"KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int. 2021;100(4S):S1\u2013276. https:\/\/doi.org\/10.1016\/j.kint.2021.05.021.","journal-title":"Kidney Int"},{"issue":"4","key":"405_CR38","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.kint.2021.05.015","volume":"100","author":"BH Rovin","year":"2021","unstructured":"Rovin BH, Adler SG, Barratt J, Bridoux F, Burdge KA, Chan TM, et al. Executive summary of the KDIGO 2021 Guideline for the management of glomerular diseases. Kidney Int. 2021;100(4):753\u201379. https:\/\/doi.org\/10.1016\/j.kint.2021.05.015.","journal-title":"Kidney Int"},{"issue":"4","key":"405_CR39","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.kint.2020.04.046","volume":"98","author":"T Rauen","year":"2020","unstructured":"Rauen T, Wied S, Fitzner C, Eitner F, Sommerer C, Zeier M, et al. After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy. Kidney Int. 2020;98(4):1044\u201352. https:\/\/doi.org\/10.1016\/j.kint.2020.04.046.","journal-title":"Kidney Int"},{"issue":"19","key":"405_CR40","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1001\/jama.2022.5368","volume":"327","author":"J Lv","year":"2022","unstructured":"Lv J, Wong MG, Hladunewich MA, Jha V, Hooi LS, Monaghan H, et al. Effect of oral methylprednisolone on decline in kidney function or kidney failure in patients with IgA nephropathy: the TESTING randomized clinical trial. JAMA. 2022;327(19):1888\u201398. https:\/\/doi.org\/10.1001\/jama.2022.5368.","journal-title":"JAMA"},{"issue":"2","key":"405_CR41","doi-asserted-by":"publisher","first-page":"e2254054","DOI":"10.1001\/jamanetworkopen.2022.54054","volume":"6","author":"FF Hou","year":"2023","unstructured":"Hou FF, Xie D, Wang J, Xu X, Yang X, Ai J, et al. Effectiveness of Mycophenolate Mofetil among patients with Progressive IgA Nephropathy: a Randomized Clinical Trial. JAMA Netw Open. 2023;6(2):e2254054. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.54054.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"405_CR42","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1186\/s12916-023-03086-0","volume":"21","author":"Q Wang","year":"2023","unstructured":"Wang Q, Shi Q, Wang Z, Lu J, Hou J. Integrating plasma proteomes with genome-wide association data for causal protein identification in multiple myeloma. Bmc Med. 2023;21(1):377. https:\/\/doi.org\/10.1186\/s12916-023-03086-0.","journal-title":"Bmc Med"},{"issue":"Suppl 1","key":"405_CR43","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.1007\/s10875-014-0031-6","volume":"34","author":"MS Ben","year":"2014","unstructured":"Ben MS, Aloulou M, Benhamou M, Monteiro RC. Role of Fc\u03b3RIIIA (CD16) in IVIg-mediated anti-inflammatory function. J Clin Immunol. 2014;34(Suppl 1):S46\u201350. https:\/\/doi.org\/10.1007\/s10875-014-0031-6.","journal-title":"J Clin Immunol"},{"issue":"6","key":"405_CR44","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/ng2046","volume":"39","author":"M Fanciulli","year":"2007","unstructured":"Fanciulli M, Norsworthy PJ, Petretto E, Dong R, Harper L, Kamesh L, et al. FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat Genet. 2007;39(6):721\u20133. https:\/\/doi.org\/10.1038\/ng2046.","journal-title":"Nat Genet"},{"issue":"13","key":"405_CR45","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1177\/0961203317700485","volume":"26","author":"Y Qi","year":"2017","unstructured":"Qi Y, Zhou X, Bu D, Hou P, Lv J, Zhang H. Low copy numbers of FCGR3A and FCGR3B associated with Chinese patients with SLE and AASV. Lupus. 2017;26(13):1383\u20139. https:\/\/doi.org\/10.1177\/0961203317700485.","journal-title":"Lupus"},{"issue":"1","key":"405_CR46","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12865-020-00344-1","volume":"21","author":"N Guo","year":"2020","unstructured":"Guo N, Zhou Q, Huang X, Yu J, Han Q, Nong B, et al. Identification of differentially expressed circulating exosomal lncRNAs in IgA nephropathy patients. Bmc Immunol. 2020;21(1):16. https:\/\/doi.org\/10.1186\/s12865-020-00344-1.","journal-title":"Bmc Immunol"},{"issue":"4","key":"405_CR47","doi-asserted-by":"publisher","first-page":"e61208","DOI":"10.1371\/journal.pone.0061208","volume":"8","author":"XJ Zhou","year":"2013","unstructured":"Zhou XJ, Cheng FJ, Qi YY, Zhao YF, Hou P, Zhu L, et al. FCGR2B and FCRLB gene polymorphisms associated with IgA nephropathy. PLoS ONE. 2013;8(4):e61208. https:\/\/doi.org\/10.1371\/journal.pone.0061208.","journal-title":"PLoS ONE"},{"issue":"27","key":"405_CR48","doi-asserted-by":"publisher","first-page":"10084","DOI":"10.1073\/pnas.0402930101","volume":"101","author":"SL Ogg","year":"2004","unstructured":"Ogg SL, Weldon AK, Dobbie L, Smith AJ, Mather IH. Expression of butyrophilin (Btn1a1) in lactating mammary gland is essential for the regulated secretion of milk-lipid droplets. Proc Natl Acad Sci U S A. 2004;101(27):10084\u20139. https:\/\/doi.org\/10.1073\/pnas.0402930101.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"405_CR49","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1186\/s12967-023-04514-8","volume":"21","author":"Y Wang","year":"2023","unstructured":"Wang Y, Ji N, Zhang Y, Chu J, Pan C, Zhang P, et al. B7H3-targeting chimeric antigen receptor modification enhances antitumor effect of V\u03b39V\u03b42 T cells in glioblastoma. J Transl Med. 2023;21(1):672. https:\/\/doi.org\/10.1186\/s12967-023-04514-8.","journal-title":"J Transl Med"},{"issue":"7977","key":"405_CR50","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41586-023-06482-x","volume":"621","author":"MR Mamedov","year":"2023","unstructured":"Mamedov MR, Vedova S, Freimer JW, Sahu AD, Ramesh A, Arce MM, et al. CRISPR screens decode cancer cell pathways that trigger \u03b3\u03b4 T cell detection. Nature. 2023;621(7977):188\u201395. https:\/\/doi.org\/10.1038\/s41586-023-06482-x.","journal-title":"Nature"},{"issue":"14","key":"405_CR51","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1007\/s00018-011-0706-6","volume":"68","author":"B Moser","year":"2011","unstructured":"Moser B, Eberl M. \u03b3\u03b4 T-APCs: a novel tool for immunotherapy? Cell Mol Life Sci. 2011;68(14):2443\u201352. https:\/\/doi.org\/10.1007\/s00018-011-0706-6.","journal-title":"Cell Mol Life Sci"},{"issue":"12","key":"405_CR52","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1002\/eji.201141404","volume":"41","author":"N Messal","year":"2011","unstructured":"Messal N, Mamessier E, Sylvain A, Celis-Gutierrez J, Thibult ML, Chetaille B, et al. Differential role for CD277 as a co-regulator of the immune signal in T and NK cells. Eur J Immunol. 2011;41(12):3443\u201354. https:\/\/doi.org\/10.1002\/eji.201141404.","journal-title":"Eur J Immunol"},{"key":"405_CR53","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1600-065X.2006.00479.x","volume":"215","author":"CT Morita","year":"2007","unstructured":"Morita CT, Jin C, Sarikonda G, Wang H. Nonpeptide antigens, presentation mechanisms, and immunological memory of human Vgamma2Vdelta2 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens. Immunol Rev. 2007;215:59\u201376. https:\/\/doi.org\/10.1111\/j.1600-065X.2006.00479.x.","journal-title":"Immunol Rev"},{"issue":"11","key":"405_CR54","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/s41419-022-05429-w","volume":"13","author":"W Yang","year":"2022","unstructured":"Yang W, Cheng B, Chen P, Sun X, Wen Z, Cheng Y. BTN3A1 promotes tumor progression and radiation resistance in esophageal squamous cell carcinoma by regulating ULK1-mediated autophagy. Cell Death Dis. 2022;13(11):984. https:\/\/doi.org\/10.1038\/s41419-022-05429-w.","journal-title":"Cell Death Dis"},{"issue":"6","key":"405_CR55","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.cell.2016.07.046","volume":"166","author":"D Daley","year":"2016","unstructured":"Daley D, Zambirinis CP, Seifert L, Akkad N, Mohan N, Werba G, et al. \u03b3\u03b4 T cells support pancreatic oncogenesis by restraining \u03b1\u03b2 T cell activation. Cell. 2016;166(6):1485\u201399. https:\/\/doi.org\/10.1016\/j.cell.2016.07.046.","journal-title":"Cell"},{"issue":"2","key":"405_CR56","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nri3384","volume":"13","author":"P Vantourout","year":"2013","unstructured":"Vantourout P, Hayday A. Six-of-the-best: unique contributions of \u03b3\u03b4 T cells to immunology. Nat Rev Immunol. 2013;13(2):88\u2013100. https:\/\/doi.org\/10.1038\/nri3384.","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"405_CR57","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/s41581-021-00466-8","volume":"17","author":"H Kaminski","year":"2021","unstructured":"Kaminski H, Couzi L, Eberl M. Unconventional T cells and kidney disease. Nat Rev Nephrol. 2021;17(12):795\u2013813. https:\/\/doi.org\/10.1038\/s41581-021-00466-8.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"405_CR58","doi-asserted-by":"publisher","first-page":"7617","DOI":"10.1038\/s41467-023-41938-8","volume":"14","author":"MM Karunakaran","year":"2023","unstructured":"Karunakaran MM, Subramanian H, Jin Y, Mohammed F, Kimmel B, Juraske C, et al. A distinct topology of BTN3A IgV and B30.2 domains controlled by juxtamembrane regions favors optimal human \u03b3\u03b4 T cell phosphoantigen sensing. Nat Commun. 2023;14(1):7617. https:\/\/doi.org\/10.1038\/s41467-023-41938-8.","journal-title":"Nat Commun"},{"issue":"7980","key":"405_CR59","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/s41586-023-06525-3","volume":"621","author":"L Yuan","year":"2023","unstructured":"Yuan L, Ma X, Yang Y, Qu Y, Li X, Zhu X, et al. Phosphoantigens glue butyrophilin 3A1 and 2A1 to activate V\u03b39V\u03b42 T cells. Nature. 2023;621(7980):840\u20138. https:\/\/doi.org\/10.1038\/s41586-023-06525-3.","journal-title":"Nature"},{"issue":"616","key":"405_CR60","doi-asserted-by":"publisher","first-page":"j835","DOI":"10.1126\/scitranslmed.abj0835","volume":"13","author":"A De Gassart","year":"2021","unstructured":"De Gassart A, Le KS, Brune P, Agaugu\u00e9 S, Sims J, Goubard A, et al. Development of ICT01, a first-in-class, anti-BTN3A antibody for activating V\u03b39V\u03b42 T cell-mediated antitumor immune response. Sci Transl Med. 2021;13(616):j835. https:\/\/doi.org\/10.1126\/scitranslmed.abj0835.","journal-title":"Sci Transl Med"},{"issue":"1","key":"405_CR61","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa0810457","volume":"361","author":"LJ Beck","year":"2009","unstructured":"Beck LJ, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361(1):11\u201321. https:\/\/doi.org\/10.1056\/NEJMoa0810457.","journal-title":"N Engl J Med"},{"issue":"6","key":"405_CR62","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.kint.2019.07.014","volume":"96","author":"AE van de Logt","year":"2019","unstructured":"van de Logt AE, Fresquet M, Wetzels JF, Brenchley P. The anti-PLA2R antibody in membranous nephropathy: what we know and what remains a decade after its discovery. Kidney Int. 2019;96(6):1292\u2013302. https:\/\/doi.org\/10.1016\/j.kint.2019.07.014.","journal-title":"Kidney Int"},{"issue":"6","key":"405_CR63","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1189\/jlb.0512231","volume":"92","author":"L Martinez-Pomares","year":"2012","unstructured":"Martinez-Pomares L. The mannose receptor. J Leukoc Biol. 2012;92(6):1177\u201386. https:\/\/doi.org\/10.1189\/jlb.0512231.","journal-title":"J Leukoc Biol"},{"issue":"1","key":"405_CR64","doi-asserted-by":"publisher","first-page":"33","DOI":"10.47102\/annals-acadmedsg.2020138","volume":"50","author":"F Wang","year":"2021","unstructured":"Wang F, Wang TT, Liang XW, Lu JD, Xie QH, Chen RY, et al. PLA2R1 and HLA-DQA1 gene variations in idiopathic membranous nephropathy in South China. Ann Acad Med Singap. 2021;50(1):33\u201341. https:\/\/doi.org\/10.47102\/annals-acadmedsg.2020138.","journal-title":"Ann Acad Med Singap"},{"issue":"1","key":"405_CR65","doi-asserted-by":"publisher","first-page":"13119","DOI":"10.1038\/s41598-020-70009-x","volume":"10","author":"M Yoshikawa","year":"2020","unstructured":"Yoshikawa M, Asaba K. Single-nucleotide polymorphism rs4664308 in PLA2R1 gene is associated with the risk of idiopathic membranous nephropathy: a meta-analysis. Sci Rep. 2020;10(1):13119. https:\/\/doi.org\/10.1038\/s41598-020-70009-x.","journal-title":"Sci Rep"},{"issue":"1","key":"405_CR66","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1681\/ASN.2019050538","volume":"31","author":"PD Burbelo","year":"2020","unstructured":"Burbelo PD, Joshi M, Chaturvedi A, Little DJ, Thurlow JS, Waldman M, et al. Detection of PLA2R autoantibodies before the diagnosis of Membranous Nephropathy. J Am Soc Nephrol. 2020;31(1):208\u201317. https:\/\/doi.org\/10.1681\/ASN.2019050538.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"405_CR67","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/j.ekir.2021.04.002","volume":"6","author":"AV Logt","year":"2021","unstructured":"Logt AV, Justino J, Vink CH, van den Brand J, Debiec H, Lambeau G, et al. Anti-PLA2R1 antibodies as Prognostic Biomarker in Membranous Nephropathy. Kidney Int Rep. 2021;6(6):1677\u201386. https:\/\/doi.org\/10.1016\/j.ekir.2021.04.002.","journal-title":"Kidney Int Rep"},{"issue":"9","key":"405_CR68","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nrneph.2017.92","volume":"13","author":"P Ruggenenti","year":"2017","unstructured":"Ruggenenti P, Fervenza FC, Remuzzi G. Treatment of membranous nephropathy: time for a paradigm shift. Nat Rev Nephrol. 2017;13(9):563\u201379. https:\/\/doi.org\/10.1038\/nrneph.2017.92.","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"405_CR69","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/cr.2011.13","volume":"21","author":"MS Hayden","year":"2011","unstructured":"Hayden MS, Ghosh S. NF-\u03baB in immunobiology. Cell Res. 2011;21(2):223\u201344. https:\/\/doi.org\/10.1038\/cr.2011.13.","journal-title":"Cell Res"},{"issue":"1","key":"405_CR70","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","volume":"5","author":"H Yu","year":"2020","unstructured":"Yu H, Lin L, Zhang Z, Zhang H, Hu H. Targeting NF-\u03baB pathway for the therapy of diseases: mechanism and clinical study. Signal Transduct Target Ther. 2020;5(1):209. https:\/\/doi.org\/10.1038\/s41392-020-00312-6.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"405_CR71","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/cr.2010.177","volume":"21","author":"SC Sun","year":"2011","unstructured":"Sun SC. Non-canonical NF-\u03baB signaling pathway. Cell Res. 2011;21(1):71\u201385. https:\/\/doi.org\/10.1038\/cr.2010.177.","journal-title":"Cell Res"},{"issue":"5","key":"405_CR72","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/nep.13446","volume":"24","author":"G Zhou","year":"2019","unstructured":"Zhou G, Xin G, Zhang W, Zhang X. Biomarker prediction for membranous nephropathy prognosis by microarray analysis. Nephrol (Carlton). 2019;24(5):526\u201333. https:\/\/doi.org\/10.1111\/nep.13446.","journal-title":"Nephrol (Carlton)"},{"issue":"3","key":"405_CR73","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s12192-020-01089-x","volume":"25","author":"N Chebotareva","year":"2020","unstructured":"Chebotareva N, Vinogradov A, Gindis A, Tao E, Moiseev S. Heat shock protein 90 and NFkB levels in serum and urine in patients with chronic glomerulonephritis. Cell Stress Chaperones. 2020;25(3):495\u2013501. https:\/\/doi.org\/10.1007\/s12192-020-01089-x.","journal-title":"Cell Stress Chaperones"},{"issue":"6","key":"405_CR74","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1681\/ASN.2021060784","volume":"33","author":"R Sealfon","year":"2022","unstructured":"Sealfon R, Mariani L, Avila-Casado C, Nair V, Menon R, Funk J, et al. Molecular characterization of Membranous Nephropathy. J Am Soc Nephrol. 2022;33(6):1208\u201321. https:\/\/doi.org\/10.1681\/ASN.2021060784.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"405_CR75","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s10875-011-9614-7","volume":"32","author":"CC Wu","year":"2012","unstructured":"Wu CC, Lu KC, Lin YF, Chen JS, Huang CF, Chen CC, et al. Pathogenic role of effector cells and immunoglobulins in cationic bovine serum albumin-induced membranous nephropathy. J Clin Immunol. 2012;32(1):138\u201349. https:\/\/doi.org\/10.1007\/s10875-011-9614-7.","journal-title":"J Clin Immunol"},{"issue":"9","key":"405_CR76","doi-asserted-by":"publisher","first-page":"e20019","DOI":"10.1016\/j.heliyon.2023.e20019","volume":"9","author":"SX Ma","year":"2023","unstructured":"Ma SX, Li XJ, Duan TT, Pei M, Zou L, Yu XY, et al. Moshen granule ameliorates membranous nephropathy by regulating NF-\u0199B\/Nrf2 pathways via aryl hydrocarbon receptor signalling. Heliyon. 2023;9(9):e20019. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e20019.","journal-title":"Heliyon"},{"key":"405_CR77","doi-asserted-by":"publisher","first-page":"727874","DOI":"10.3389\/fphar.2021.727874","volume":"12","author":"X Wang","year":"2021","unstructured":"Wang X, Liu J, Tian R, Zheng B, Li C, Huang L, et al. Sanqi oral solution mitigates Proteinuria in Rat Passive Heymann Nephritis and blocks Podocyte apoptosis via Nrf2\/HO-1 pathway. Front Pharmacol. 2021;12:727874. https:\/\/doi.org\/10.3389\/fphar.2021.727874.","journal-title":"Front Pharmacol"},{"key":"405_CR78","doi-asserted-by":"publisher","first-page":"152913","DOI":"10.1016\/j.phymed.2019.152913","volume":"59","author":"B Liu","year":"2019","unstructured":"Liu B, Lu R, Li H, Zhou Y, Zhang P, Bai L, et al. Zhen-Wu-Tang ameliorates membranous nephropathy rats through inhibiting NF-\u03baB pathway and NLRP3 inflammasome. Phytomedicine. 2019;59:152913. https:\/\/doi.org\/10.1016\/j.phymed.2019.152913.","journal-title":"Phytomedicine"},{"issue":"5","key":"405_CR79","doi-asserted-by":"publisher","first-page":"e18970","DOI":"10.1097\/MD.0000000000018970","volume":"99","author":"Y Jin","year":"2020","unstructured":"Jin Y, Zhang J, Wang Y, Xiao X, Zhang Q. Tripterygium Wilfordii multiglycosides combined with prednisone in the treatment of idiopathic membranous nephropathy: a protocol for a systematic review and meta-analysis. Med (Baltim). 2020;99(5):e18970. https:\/\/doi.org\/10.1097\/MD.0000000000018970.","journal-title":"Med (Baltim)"},{"key":"405_CR80","doi-asserted-by":"publisher","first-page":"7069052","DOI":"10.1155\/2020\/7069052","volume":"2020","author":"Q Di Tu","year":"2020","unstructured":"Di Tu Q, Jin J, Hu X, Ren Y, Zhao L, He Q. Curcumin improves the renal autophagy in Rat Experimental Membranous Nephropathy via regulating the PI3K\/AKT\/mTOR and Nrf2\/HO-1 signaling pathways. Biomed Res Int. 2020;2020:7069052. https:\/\/doi.org\/10.1155\/2020\/7069052.","journal-title":"Biomed Res Int"},{"key":"405_CR81","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.cbi.2017.07.011","volume":"274","author":"B Sutariya","year":"2017","unstructured":"Sutariya B, Taneja N, Saraf M. Betulinic acid, isolated from the leaves of Syzygium cumini (L.) Skeels, ameliorates the proteinuria in experimental membranous nephropathy through regulating Nrf2\/NF-\u03baB pathways. Chem Biol Interact. 2017;274:124\u201337. https:\/\/doi.org\/10.1016\/j.cbi.2017.07.011.","journal-title":"Chem Biol Interact"},{"key":"405_CR82","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.phymed.2018.12.045","volume":"57","author":"Z Sen","year":"2019","unstructured":"Sen Z, Weida W, Jie M, Li S, Dongming Z, Xiaoguang C. Coumarin glycosides from Hydrangea paniculata slow down the progression of diabetic nephropathy by targeting Nrf2 anti-oxidation and smad2\/3-mediated profibrosis. Phytomedicine. 2019;57:385\u201395. https:\/\/doi.org\/10.1016\/j.phymed.2018.12.045.","journal-title":"Phytomedicine"}],"container-title":["BioData Mining"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13040-024-00405-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13040-024-00405-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13040-024-00405-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T09:04:31Z","timestamp":1731056671000},"score":1,"resource":{"primary":{"URL":"https:\/\/biodatamining.biomedcentral.com\/articles\/10.1186\/s13040-024-00405-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,8]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["405"],"URL":"https:\/\/doi.org\/10.1186\/s13040-024-00405-w","relation":{},"ISSN":["1756-0381"],"issn-type":[{"type":"electronic","value":"1756-0381"}],"subject":[],"published":{"date-parts":[[2024,11,8]]},"assertion":[{"value":"27 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study was conducted based on publicly available GWAS data and did not require ethical approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors were involved in the writing and revision of the article, and all authors approved the submitted version to be published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"49"}}